$1.61
1.23% day before yesterday
Nasdaq, Jan 02, 10:17 pm CET
ISIN
KYG108301006
Symbol
BYSI

BeyondSpring Inc. Stock price

$1.61
-0.36 18.27% 1M
-0.68 29.69% 6M
-0.02 1.23% YTD
+0.02 1.26% 1Y
-0.27 14.36% 3Y
-10.55 86.76% 5Y
-15.19 90.42% 10Y
-15.19 90.42% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.02 1.23%
ISIN
KYG108301006
Symbol
BYSI
Industry

Key metrics

Basic
Market capitalization
$66.2m
Enterprise Value
$53.6m
Net debt
positive
Cash
$12.6m
Shares outstanding
40.3m
Valuation (TTM | estimate)
P/E
negative | -
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-95.9%
Return on Equity
33.8%
ROCE
-91.0%
ROIC
-289.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | -
EBITDA
$-14.9m | -
EBIT
$-15.1m | -
Net Income
$-10.0m | -
Free Cash Flow
$-14.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-0.2
FCF per Share
$-0.4
Short interest
7.3%
Employees
40
Rev per Employee
$0.0
Show more

Is BeyondSpring Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

BeyondSpring Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a BeyondSpring Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a BeyondSpring Inc. forecast:

Buy
86%
Hold
14%

Financial data from BeyondSpring Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 9.54 9.54
-
-
- Research and Development Expense 5.56 5.56
-
-
-15 -15
-
-
- Depreciation and Amortization 0.24 0.24
-
-
EBIT (Operating Income) EBIT -15 -15
-
-
Net Profit -9.99 -9.99
-
-

In millions USD.

Don't miss a Thing! We will send you all news about BeyondSpring Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BeyondSpring Inc. Stock News

Neutral
GlobeNewsWire
22 days ago
FLORHAM PARK, N.J., Dec. 12, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a clinical-stage biopharmaceutical company developing first-in-class immune-modulating cancer therapies, today announced results from the Asian subset (n=488) of its global Phase 3 DUBLIN-3 trial evaluating Plinabulin plus docetaxel compared to docetaxel alone in second- or third-line EGFR wild-type non-smal...
Neutral
Seeking Alpha
4 months ago
BeyondSpring Inc. (NASDAQ:BYSI ) 2025 Annual Shareholders Meeting Call September 15, 2025 9:00 AM EDT Company Participants Lan Huang - Co-Founder, Chairman & CEO Presentation Unknown Attendee Good morning, and welcome to the 2025 Annual Meeting of Shareholders of BeyondSpring Inc. Lan Huang Co-Founder, Chairman & CEO Good morning. I'm Lan Huang, Chair of Board of Directors and Chief Executive O...
Neutral
GlobeNewsWire
6 months ago
FLORHAM PARK, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) today announced publication of a human clinical study in Med (Cell Press) demonstrating that Plinabulin, when combined with radiation and a checkpoint inhibitor, induces dendritic cell (DC) maturation and elicits tumor responses in patients across multiple cancer types who had failed prior ICI therapy. The st...

Company Profile

BeyondSpring, Inc. is a clinical stage company, which engages in the development of cancer therapies. It focuses on non-small cell lung cancer, neutropenia prevention, and plinabulin and nivolumab. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.

Head office Cayman Islands
CEO Lan Huang
Employees 40
Founded 2010
Website www.beyondspringpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today